Fact CheckerSign in

NCT07204392Recruiting

Unveiling the Germline Predisposition to Myeloproliferative Neoplasms

Source: ClinicalTrials.gov · Last updated 2 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The classic Ph-negative myeloproliferative neoplasms (MPN) are a group of clonal hematopoietic disorders caused by a dysregulated JAK/STAT signal transduction because of acquired somatic mutations of JAK2, CALR or MPL genes. They are sporadic diseases but there are several lines of evidence that support the role of germline factors in the pathogenesis of MPN: the existence of familial clustering, the presence of more than one clone in some patients, the known existence of common polymorphisms that cause predisposition to MPN. In this study, we would like to define the germline predisposition to MPN.

Status (registry)
Recruiting
Study type
Observational
Enrollment
313 (estimated)
First submitted
24 Sept 2025
Start date
27 Jun 2022
Primary completion date
31 Dec 2030
Lead sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
NCT number
NCT07204392

What you commit to

  • Study type: Observational
  • Planned participants: 313
  • From 27 Jun 2022 to the primary completion date, 31 Dec 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • None

Who the study is looking for

  • A diagnosis of PV, ET, prePMF, overt PMF or MPN-U according to 2016 WHO criteria
  • Characterization of the MPN driver mutation performed at any moment before enrolment
  • diagnosis of MPN made when the patient was younger than 27 years old OR at least a second case of hematologic malignancies in first or second-degree relatives

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Fondazione IRCCS Policlinico San Matteo
Coordinator of this site? Confirm its status
PaviaItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.